Aug 31 2020

Halberd Selects Arizona State University (ASU) to Develop Its Patented Covid-19 Treatment(s)

By |2020-08-31T08:00:31-04:00August 31st, 2020|Featured, Investor News, News|0 Comments

Jackson Center, PA, August 31, 2020 – Halberd Corporation (OTC PINK: "HALB") today announced the signing of a development agreement with Arizona State University (ASU) to conduct sponsored research to develop Halberd’s Covid-19 treatments.  The work will focus on developing antibodies in support of Halberd’s two issued patents and three Covid-19 related provisional patent applications ...

Aug 27 2020

Halberd Corporation Selects University Research Partner

By |2020-08-27T08:00:21-04:00August 27th, 2020|Featured, News, Technology|0 Comments

Jackson Center, PA, August 27, 2020 – Halberd Corp. (OTC PINK: "HALB") is pleased to announce the successful completion of its search for a major research university partner. The University, to be announced, is engaged to develop compounds for use in Halberd’s patented extracorporeal treatment of Covid-19.  Terms of the agreement have been finalized and ...

Aug 4 2020

Halberd Corporation Secures $2 Million for Covid-19 Research

By |2020-08-04T08:00:29-04:00August 4th, 2020|Featured, Investor News, News|0 Comments

Jackson Center, PA, August 4, 2020 – Halberd Corp. (OTC PINK: "HALB") announced today that they have secured non-dilutive, grant-based funding for their patent pending Covid-19 treatment(s).  Newly formed Nonprofit Organization, Epidemiologic Solutions Corporation, a Louisiana, Internal Revenue Code Section 501(c)(3) application pending, has committed to provide funding of approximately $2,000,000, as required by Halberd ...

Go to Top